 Better diagnostics, especially those that are useful at the point of care to guide clinical decision making about whether and what agent to prescribe. These diagnostic tests should be affordable and feasible also in resource-poor settings.  Enhanced understanding of how antibiotics are processed in the body, their effect on an individual's microbiological ecology, and studies of treatment efficacy and effectiveness.  Enhanced surveillance on the incidence of infections, the way they are currently treated, clinical outcomes, and the influence of antimicrobial resistance, so we can better know where we are headed and model the effect of any possible changes in practice. Data will need to be clinically useful and better used in informing clinical decision-making, clinical guidelines and policy development.  Associated costs and cost effectiveness.  Improved ways of achieving translating new, robust evidence in clinical care in a wide range of settings internationally.  Improving prevention of infections through changed lifestyle of individuals and communities, better farming methods, improved immunization and reduced opportunities for transmission.  Enhanced access to effective antibiotics for those who will benefit and better ways of curtailing use where they are not effective  How different classes of antibiotics, infection related strategies, and antibiotic use in humans and animals interact to produce both beneficial and unwanted outcomes. We need to see the world in an integrated, systemic way.
Antibiotics: Proudly International, Multidisciplinary, Bold and Eclectic
To achieve these broad aims of biomedical innovation and antimicrobial stewardship, we will need the integrated perspectives of the clinical, mathematical, social, veterinary, economic, marketing, and policy sciences to first better understand the complexity of the culture and consequences of antibiotic use and human behavior in relation to infections, and then to develop, implement and evaluate the required innovations.
So Antibiotics aims to bring together the relevant disciplinary perspective, including user perspectives, from around the world to contribute additional fresh impetus within the field. We will publish not only traditional research but also innovative, speculative perspectives, provided the criterion of scientific rigor is always met. We will welcome a broad range of research methods, so long as these are rigorous and appropriate to the research question. We will be nimble, fair and effective. We aim to become the leading and most vibrant open access journal in the field.
Antibiotics: A Journal with a Values Based Mission
Humanity faces a complex future. The challenges around preserving and developing antibiotic effectiveness are a microcosm of the challenges to humanity's very existence; how do we maximize benefit from human ingenuity without destroying our future through failing to address the consequences of our current hubris? Good science and its timely, effective dissemination will contribute to this broad mission. With your support, this exciting new journal will rise to the challenge!
